Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2007;11(1):115.
doi: 10.1186/cc5156.

Antithrombin and hypercoagulability in sepsis: insights from thrombelastography?

Johannes N Hoffmann  1 , Kerstin Schick
Affiliations
Comment

Antithrombin and hypercoagulability in sepsis: insights from thrombelastography?

Johannes N Hoffmann et al. Crit Care. 2007.

Abstract

Antithrombin (AT) has been used for over 25 years to successfully treat disseminated intravascular coagulation (DIC). A four-day AT therapy in patients with DIC in the KyberSept trial has been related to a clear survival benefit in patients not receiving concomitant heparin. Gonano and coworkers performed thrombelastography (TEG) measurements in patients with severe sepsis and clearly showed hypercoagulability, as defined by five TEG parameters, compared to healthy controls. In the AT group they found a trend towards normalization of TEG parameters after treatment, although this did not reach statistical significance. This first clinical evaluation of hypercoagulability during AT treatment could not provide evidence for an attenuation of coagulopathy, an effect that might be due to high inter-individual variability.

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Gonano C, Sitzwohl C, Meitner E, Weinstabl C, Kettner SC. Four-day antithrombin therapy does not seem to attenuate hypercoagulability in patients suffering from sepsis. Crit Care. 2006;10:R160. doi: 10.1186/cc5098. - DOI - PMC - PubMed
    1. Bone RC. Modulators of coagulation. A critical appraisal of their role in sepsis. Arch Intern Med. 1992;152:1381–1389. doi: 10.1001/archinte.152.7.1381. - DOI - PubMed
    1. Cohen JR, Sarfati I, Birnbaum E, Benacquista T, Wise L. The inactivation of antithrombin III by serum elastase in patients with surgical infections. Am Surg. 1990;56:665–667. - PubMed
    1. Blatt PM, White GC, 2nd, Goldsmith JC, Roberts HR. Antithrombin-III transfusion in disseminated intravascular coagulation. Lancet. 1978;1:1212. doi: 10.1016/S0140-6736(78)91006-1. - DOI - PubMed
    1. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kübler A, et al. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA. 2001;286:1869–1878. doi: 10.1001/jama.286.15.1869. - DOI - PubMed